Sinocare Inc
SZSE:300298
Intrinsic Value
Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. [ Read More ]
The intrinsic value of one Sinocare Inc stock under the Base Case scenario is 36.43 CNY. Compared to the current market price of 22.73 CNY, Sinocare Inc is Undervalued by 38%.
Valuation Backtest
Sinocare Inc
Run backtest to discover the historical profit from buying and selling Sinocare Inc stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sinocare Inc
Current Assets | 2.4B |
Cash & Short-Term Investments | 986.6m |
Receivables | 610.4m |
Other Current Assets | 765m |
Non-Current Assets | 3.9B |
Long-Term Investments | 438.2m |
PP&E | 1.8B |
Intangibles | 1.5B |
Other Non-Current Assets | 171.4m |
Current Liabilities | 1.5B |
Accounts Payable | 266.2m |
Accrued Liabilities | 250.8m |
Short-Term Debt | 415.3m |
Other Current Liabilities | 571.5m |
Non-Current Liabilities | 1.7B |
Long-Term Debt | 1B |
Other Non-Current Liabilities | 710.6m |
Earnings Waterfall
Sinocare Inc
Revenue
|
3.9B
CNY
|
Cost of Revenue
|
-1.8B
CNY
|
Gross Profit
|
2B
CNY
|
Operating Expenses
|
-1.5B
CNY
|
Operating Income
|
476.8m
CNY
|
Other Expenses
|
-91.3m
CNY
|
Net Income
|
385.5m
CNY
|
Free Cash Flow Analysis
Sinocare Inc
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Sinocare Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Score
Sinocare Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sinocare Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Score
Sinocare Inc's solvency score is 62/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sinocare Inc
According to Wall Street analysts, the average 1-year price target for Sinocare Inc is 32.34 CNY with a low forecast of 27.27 CNY and a high forecast of 35.83 CNY.
Shareholder Return
Price
Sinocare Inc
Average Annual Return | 39.8% |
Standard Deviation of Annual Returns | 64.85% |
Max Drawdown | -71% |
Market Capitalization | 12.7B CNY |
Shares Outstanding | 564 265 373 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sinocare, Inc. engages in the research, development, manufacture, and commercialization of biosensor-based blood glucose monitoring systems. The company is headquartered in Changsha, Hunan and currently employs 3,534 full-time employees. The company went IPO on 2012-03-19. The firm mainly provides micro blood instant blood sugar monitoring systems including blood sugar testing instruments and related blood sugar testing strips, as well as blood sugar testing systems and mobile blood sugar instruments, among others. The firm also provides diabetes management information systems. The company distributes its products within domestic market and to overseas markets under the brand name of SANNUO.
Contact
IPO
Employees
Officers
The intrinsic value of one Sinocare Inc stock under the Base Case scenario is 36.43 CNY.
Compared to the current market price of 22.73 CNY, Sinocare Inc is Undervalued by 38%.